SCHEMBL7946218

SCHEMBL7946218

Nc1ccnc2c1nc(-c1cccc(F)c1)c(=O)n2C1CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 19/20 0.60
CYP3A4 P08684 8/20 0.60
CYP2C9 P11712 7/20 0.45
TSHR P16473 6/20 0.45
ALOX15 P16050 4/20 0.44
ALDH1A1 P00352 13/20 0.43
USP2 O75604 7/20 0.43
MAPK1 P28482 4/20 0.43
HSD17B10 Q99714 7/20 0.42
CASP1 P29466 5/20 0.42
CASP7 P55210 5/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 3/20 0.42
CYP2C19 P33261 1/20 0.42
AKT1 P31749 1/20 0.41
MTOR P42345 1/20 0.41
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
LMNA P02545 2/20 0.40
CLK4 Q9HAZ1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7938231 0.87 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7943737 0.86 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL3223334 0.84 CYP1A2 (0.55) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7938293 0.82 CYP1A2 (0.48) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7947972 0.82 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C9TSHRALDH1A1
SCHEMBL7937482 0.82 CYP1A2 (0.46) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7937742 0.81 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL927379 0.81 CYP1A2 (0.72) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7944111 0.81 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C9TSHRALOX15
SCHEMBL7944713 0.79 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C9TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed